Contents

Contributors vii

Preface to the third edition ix

Preface to the second edition x

PART I SETTING THE SCENE

1 The concept of scientific dishonesty: ethics, value systems, and research 3

Povl Riis

2 Regulations on scientific misconduct: lessons from the US experience 13

Drummond Rennie, C Kristina Gunsalus

3 Pay cheques on a Saturday night: the changing politics and bureaucracy of research integrity in the United States 32

Marcel C La Follette

PART II THE HISTORY OF FRAUD AND MISCONDUCT

4 Research misconduct 1974-1990: an imperfect history 51

Stephen Lock

5 Counteracting research misconduct: a decade of

British pharmaceutical industry action 64

Frank Wells

PART III NATIONAL PRACTICAL ISSUES

6 A pharmaceutical company's approach to the threat of research fraud 89

Peter Brock

7 Role of the FDA, NIH, and other bodies in the United States 105

Arthur Horowitz

8 The Danish committees on scientific dishonesty 126

Hans Henrik Brydensholt

9 Scientific fraud and misconduct in Finland 131

Veikko Launis

10 Experiences of fraud and misconduct in healthcare research in Norway 134

Magne Nylenna

11 Dealing with misconduct in science: German efforts 140

Stefanie Stegemann-Boehl

12 Fraud and misconduct in medical research in France 152

Jean-Marc Husson, Jean-Paul Demarez

PART IV ETHICS AND STATISTICS

13 The role of research ethics committees 173

Jennifer Blunt

14 Statistical aspects of the detection of fraud 186

Stephen Evans

PART V PERSONAL EXPERIENCES

15 Whistleblower 207 David Edwards

16 Research fraud/misconduct: a glance at the human side 216

Peter Jay part vi the role of the editor

17 Fraud and misconduct in medical research: prevention 225

Lesley H Rees

18 Research misconduct: an editor's view 244 Michael Farthing

Appendix: Standard operating procedure (SOP) for the handling of suspected fraud/misconduct 257

Index 261

Was this article helpful?

0 0

Post a comment